In our samples, we observed a high percentage of tumor cells harboring IL12RB2 mutations (i.e., high CCF), though it remains unclear whether the IL12RB2 mutations play any functional roles in influencing the inflammatory pathways. The gene discussed is IL12RB2; the disease is neoplasm.